Chief Advancement Officer
Lupus Research Alliance
The Lupus Research Alliance seeks a Chief Advancement Officer to align, plan, manage, and execute a comprehensive, diversified, and strategic development and marketing and communications effort to further advance the organization's mission with the mandate of significantly growing and diversifying sources of revenue from all constituents. The Chief Advancement Officer will provide strategic vision and an innovative approach to this endeavor, ensuring that the development and marketing and communications teams are fully integrated to tell the Lupus Research Alliance's story in a compelling and impactful way to drive constituent engagement and fundraising growth.
The Lupus Research Alliance (LRA) is the largest nongovernmental, nonprofit funder of lupus research in the world. LRA aims to transform treatment while advancing toward a cure by funding the most innovative lupus research; fostering diverse scientific talent; stimulating collaborations; and driving discovery toward better diagnostics, improved treatments, and ultimately, a cure for lupus. Because the Lupus Research Alliance’s Board of Directors funds all administrative and fundraising costs, 100% of all donations goes to support lupus research programs. Lupus Research Alliance is the world’s leading catalyst driving innovative research that can transform the lives of all affected by the disease—patients, their loved ones, and the entire Lupus Community. In 2016, the LRI, the S.L.E. Lupus Foundation, and the ALR merged to form the most comprehensive private-sector organization supporting biomedical research in lupus. This landmark merger united the leading lupus research organizations in a single unwavering focus: support the best new science to prevent, treat, and cure lupus. By pushing the limits of scientific exploration and shepherding new discoveries into potential treatments, the organization aims to seize every opportunity that will help ease the burden of people living with this difficult disease.
The Lupus Research Alliance, along with its affiliate Lupus Therapeutics, is the only organization focused on the complete spectrum of lupus research from transformative discoveries in the lab through clinical trials leading to new medications. The LRA will leave no stone unturned when it comes to looking for new treatments for people with lupus, making its aim for safer, more effective, and more targeted treatment options a tangible reality.
"With the lupus research landscape evolving to precision-based medicine approaches, the mission of the LRA could not be more urgent or important: drive the discovery and development of new diagnostics and treatments through innovative research and collaborations, while keeping patients at the center of everything we do. The key to turning our plan into life-changing breakthroughs for people with lupus will be the inspiration we draw from our passionate and committed donors, Board of Directors, incredible staff, and world-class scientific collaborators. It’s an exhilarating and pivotal time at the LRA and we couldn’t be more energized to embrace the challenge that lies ahead. If a challenge of this magnitude excites you, then this opportunity may be right for you. Thank you for your interest in this important professional opportunity." — Albert T. Roy, President and Chief Executive Officer
For more information, including core competencies and qualifications, please refer to the full prospectus.
The Lupus Research Alliance (LRA) is the largest nongovernmental, nonprofit funder of lupus research in the world. LRA aims to transform treatment while advancing toward a cure by funding the most innovative lupus research; fostering diverse scientific talent; stimulating collaborations; and driving discovery toward better diagnostics, improved treatments, and ultimately, a cure for lupus. Because the Lupus Research Alliance’s Board of Directors funds all administrative and fundraising costs, 100% of all donations goes to support lupus research programs. Lupus Research Alliance is the world’s leading catalyst driving innovative research that can transform the lives of all affected by the disease—patients, their loved ones, and the entire Lupus Community. In 2016, the LRI, the S.L.E. Lupus Foundation, and the ALR merged to form the most comprehensive private-sector organization supporting biomedical research in lupus. This landmark merger united the leading lupus research organizations in a single unwavering focus: support the best new science to prevent, treat, and cure lupus. By pushing the limits of scientific exploration and shepherding new discoveries into potential treatments, the organization aims to seize every opportunity that will help ease the burden of people living with this difficult disease.
The Lupus Research Alliance, along with its affiliate Lupus Therapeutics, is the only organization focused on the complete spectrum of lupus research from transformative discoveries in the lab through clinical trials leading to new medications. The LRA will leave no stone unturned when it comes to looking for new treatments for people with lupus, making its aim for safer, more effective, and more targeted treatment options a tangible reality.
"With the lupus research landscape evolving to precision-based medicine approaches, the mission of the LRA could not be more urgent or important: drive the discovery and development of new diagnostics and treatments through innovative research and collaborations, while keeping patients at the center of everything we do. The key to turning our plan into life-changing breakthroughs for people with lupus will be the inspiration we draw from our passionate and committed donors, Board of Directors, incredible staff, and world-class scientific collaborators. It’s an exhilarating and pivotal time at the LRA and we couldn’t be more energized to embrace the challenge that lies ahead. If a challenge of this magnitude excites you, then this opportunity may be right for you. Thank you for your interest in this important professional opportunity." — Albert T. Roy, President and Chief Executive Officer
For more information, including core competencies and qualifications, please refer to the full prospectus.